- Home
- ESPR vs LDP Comparison
ESPR vs LDP Comparison
Compare ESPR & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- LDP
- Stock Information
- Founded
- ESPR 2008
- LDP 2012
- Country
- ESPR United States
- LDP United States
- Employees
- ESPR N/A
- LDP N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- ESPR Health Care
- LDP Finance
- Exchange
- ESPR Nasdaq
- LDP Nasdaq
- Market Cap
- ESPR 660.1M
- LDP 628.4M
- IPO Year
- ESPR 2013
- LDP N/A
- Fundamental
- Price
- ESPR $3.68
- LDP $21.20
- Analyst Decision
- ESPR Buy
- LDP
- Analyst Count
- ESPR 7
- LDP 0
- Target Price
- ESPR $6.86
- LDP N/A
- AVG Volume (30 Days)
- ESPR 7.0M
- LDP 102.5K
- Earning Date
- ESPR 11-06-2025
- LDP 01-01-0001
- Dividend Yield
- ESPR N/A
- LDP 7.91%
- EPS Growth
- ESPR N/A
- LDP N/A
- EPS
- ESPR N/A
- LDP N/A
- Revenue
- ESPR $303,802,000.00
- LDP N/A
- Revenue This Year
- ESPR $18.83
- LDP N/A
- Revenue Next Year
- ESPR N/A
- LDP N/A
- P/E Ratio
- ESPR N/A
- LDP N/A
- Revenue Growth
- ESPR 2.83
- LDP N/A
- 52 Week Low
- ESPR $0.69
- LDP $16.16
- 52 Week High
- ESPR $3.94
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- ESPR 71.27
- LDP 44.87
- Support Level
- ESPR $2.66
- LDP $20.76
- Resistance Level
- ESPR $3.26
- LDP $21.12
- Average True Range (ATR)
- ESPR 0.23
- LDP 0.21
- MACD
- ESPR 0.05
- LDP -0.06
- Stochastic Oscillator
- ESPR 94.43
- LDP 35.66
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.